HEALTH● LOWAug 14 · Aug 14, 2026, 7:29 AM
U.S. FDA issues warning letter to Aurobindo Pharma’s subsidiary Eugia Pharma
The Hindu
A formulation manufacturing unit of subsidiary Eugia Pharma Specialities near Hyderabad had earlier received four observations and an Official Action Indicated (OAI) status from the regulator
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH19m agoProbiotic cuts risk of respiratory infections in formula-fed babiesNew ScientistHEALTH49m agoCleft lip and palate and other craniofacial surgery for kids isn’t cosmetic, it’s lifesavingThe HillHEALTH1h agoHong Kong’s Hospital Authority appeals for liver donor for boy, 13South China Morning PostHEALTH1h agoInside Bunia’s fight to protect families from DRC’s deadliest Ebola outbreakRFI [en]